Recent Finacing
Recent Raise
ABOzymes is a preclinical biotech developing an enzyme platform to convert blood group A antigens to group O for kidney, lung, other organ transplants and blood products.
Focus Areas
Funding round
See the team members at Avivo Biomedical.
